Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study
Objectives: The increasing incidence of fluoroquinolones (FQ) resistance may lower its efficacy in preventing UTI following transrectal ultrasound-guided prostate biopsy (TRUS-PB). We assessed the efficacy and safety of FQ and fosfomycin-trometamol (FT) in patients undergoing TRUS-PB. Methods: A pro...
Main Authors: | Tristan Delory, Annabelle Goujon, Alexandra Masson-Lecomte, Pauline Arias, Anthony Laurancon-Fretar, Béatrice Bercot, Pierre Mongiat-Artus, Jean-Michel Molina, Matthieu Lafaurie |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220322694 |
Similar Items
-
War and Peace: the difficult treatment of urinary tract infections and fosfomycin trometamol
by: Palagin I.S., et al.
Published: (2021-04-01) -
Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora
by: Do Gyeong Lim, et al.
Published: (2021-09-01) -
In-vitro activity of fosfomycin trometamol and some other antibiotics against Escherichia coli strains isolated from urinary tract infections
by: Alicem Tekin, et al.
Published: (2011-09-01) -
Extended-Spectrum Beta-Lactamase Positivity and In Vitro Activity of Fosfomycin Trometamol and Other Antibiotics in Escherichia coli Strains Isolated from Community-Acquired Urinary Tract Infections
by: Laser ŞANAL
Published: (2012-12-01) -
In Vitro Activity of Fosfomycin Trometamol Against Extended-Spectrum Beta-Lactamase Producing Escherichia coli Strains Isolated from Community-Acquired Urinary Tract Infections
by: Meliha Çağla SÖNMEZER, et al.
Published: (2016-12-01)